FIELD: medicaments.
SUBSTANCE: invention relates to a medicament for relapsing-remitting or secondary progressive multiple sclerosis during recurrence and containing a benzopyran derivative represented by the following general formula 3, or a pharmacologically acceptable salt thereof: wherein R1 is a methyl or ethyl group; one of R2 and R3 is a hydrogen atom; and the other one of R2 and R3 is a hydrogen atom, an amino group, an acylamino group, a carbamoyl group, optionally substituted with a methyl group or a phenyl group.
EFFECT: new medicament is presented that may find use in the treatment of relapsing-remitting or secondary progressive multiple sclerosis during recurrence.
Formula 3
4 cl, 1 dwg, 4 tbl, 4 ex
Title | Year | Author | Number |
---|---|---|---|
THERAPEUTIC AGENT FOR DISEASES BASED ON INHIBITING ACTION ON MICROPHAGING MIGRATION INHIBITION FACTOR | 2014 |
|
RU2641301C2 |
ACID ADDITION SALT OF TRK INHIBITING COMPOUND | 2015 |
|
RU2708236C2 |
METHOD OF TREATMENT OF PATIENTS WITH PROSTATE BENIGNITY HYPERPLASIA, PHARMACEUTICAL PREPARATION CONTAINING INHIBITOR OF 5-ALPHA-REDUCTASE | 1992 |
|
RU2125879C1 |
NEW TREATMENT OF MULTIPLE SCLEROSIS (MS) | 2011 |
|
RU2595861C2 |
TRK-INHIBITING COMPOUND | 2014 |
|
RU2667907C9 |
HETEROCYCLIC COMPOUND | 2018 |
|
RU2780892C2 |
SULFONAMIDE COMPOUNDS AND SALTS THEREOF | 2009 |
|
RU2481329C2 |
SULPHONAMIDE COMPOUND AND SALT THEREOF | 2007 |
|
RU2425029C2 |
DIAMINOHETEROCYCLIC CARBOXAMIDE COMPOUND | 2010 |
|
RU2526253C2 |
TETRAHYDROISOQUINOLIN-1-ONE DERIVATIVE OR PHARMACEUTICALLY ACCEPTABLE SALT THEREOF, USEFUL AS BB2 ANTAGONIST | 2008 |
|
RU2479578C2 |
Authors
Dates
2021-06-29—Published
2014-07-17—Filed